Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

CARS

Cars.com

May 31 • 04:00PM ET

20.23

Dollar change +0.19
Percentage change 0.95	%

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IJR VTI IWM VB VBR AVUV VXF IJT IWO SCHA

Index	RUT	P/E	12.86	EPS (ttm)	1.57	Insider Own	8.59%	Shs Outstand	65.93M	Perf Week	9.41%
Market Cap	1.34B	Forward P/E	8.84	EPS next Y	2.29	Insider Trans	-3.07%	Shs Float	60.44M	Perf Month	21.94%
Income	107.75M	PEG	0.66	EPS next Q	0.45	Inst Own	89.26%	Short Float	2.64%	Perf Quarter	8.76%
Sales	702.29M	P/S	1.90	EPS this Y	-50.93%	Inst Trans	-7.91%	Short Ratio	3.53	Perf Half Y	8.07%
Book/sh	7.27	P/B	2.78	EPS next Y	20.01%	ROA	10.04%	Short Interest	1.60M	Perf Year	14.62%
Cash/sh	0.47	P/C	42.65	EPS next 5Y	19.60%	ROE	24.87%	52W Range	14.82 - 22.84	Perf YTD	6.64%
Dividend Est.	-	P/FCF	9.54	EPS past 5Y	25.84%	ROI	11.28%	52W High	-11.43%	Beta	2.15
Dividend TTM	-	Quick Ratio	1.62	Sales past 5Y	1.21%	Gross Margin	52.97%	52W Low	36.50%	ATR (14)	0.53
Dividend Ex-Date	-	Current Ratio	1.62	EPS Y/Y TTM	344.25%	Oper. Margin	7.65%	RSI (14)	76.30	Volatility	3.00% 2.78%
Employees	1700	Debt/Eq	0.98	Sales Y/Y TTM	5.97%	Profit Margin	15.34%	Recom	1.86	Target Price	23.50
Option/Short	Yes / Yes	LT Debt/Eq	0.98	EPS Q/Q	-93.15%	Payout	0.00%	Rel Volume	1.32	Prev Close	20.04
Sales Surprise	0.41%	EPS Surprise	-11.69%	Sales Q/Q	7.85%	Earnings	May 09 BMO	Avg Volume	452.84K	Price	20.23
SMA20	10.97%	SMA50	16.41%	SMA200	13.32%	Trades		Volume	598,344	Change	0.95%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-15-23	Initiated	UBS	Neutral	$20
Jul-20-23	Initiated	B. Riley Securities	Buy	$26
Jun-27-23	Initiated	JP Morgan	Overweight	$23
Jun-21-22	Reiterated	BTIG Research	Buy	$19 → $16
Feb-02-22	Initiated	Northcoast	Neutral
Aug-27-21	Initiated	Truist	Buy	$18
Mar-01-21	Upgrade	The Benchmark Company	Hold → Buy	$18
Oct-15-20	Upgrade	Craig Hallum	Hold → Buy	$14
Oct-15-20	Upgrade	B. Riley Securities	Neutral → Buy	$9 → $11
May-08-20	Downgrade	Citigroup	Buy → Neutral
May-07-20	Downgrade	Craig Hallum	Buy → Hold
May-05-20	Downgrade	B. Riley FBR	Buy → Neutral	$13 → $5.25
Mar-09-20	Upgrade	BTIG Research	Neutral → Buy	$10
Mar-05-20	Upgrade	DA Davidson	Neutral → Buy
Nov-06-19	Upgrade	CFRA	Hold → Buy
Nov-06-19	Upgrade	Barrington Research	Mkt Perform → Outperform
Sep-16-19	Upgrade	Craig Hallum	Hold → Buy	$15
Aug-06-19	Downgrade	DA Davidson	Buy → Neutral
Aug-06-19	Downgrade	Barrington Research	Outperform → Mkt Perform
Aug-05-19	Downgrade	BTIG Research	Buy → Neutral

Show Previous Ratings

Today 02:45AM	Insider Sale: CEO Thomas Vetter Sells 25,373 Shares of Cars.com Inc (CARS) (GuruFocus.com)
May-24-24 12:00PM	Cars.com (CARS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:55AM	Does Cars.com (CARS) Have the Potential to Rally 32.07% as Wall Street Analysts Expect? (Zacks)
09:40AM	Are Investors Undervaluing Cars.com (CARS) Right Now? (Zacks)
May-16-24 07:30AM	Cars Commerce April Industry Insights Report Reveals New-Car Inventory Up 35% YoY but Remains a Million Units Below 2019 Levels With Prices Up 30% in the Same Time Frame (PR Newswire)
07:02PM	Loading…
May-13-24 07:02PM	Insider Selling: CEO Thomas Vetter Sells 27,625 Shares of Cars.com Inc (CARS) (GuruFocus.com)
May-10-24 01:53PM	Cars.com Inc (CARS) Q1 2024 Earnings: Modest Profit Amid Revenue Growth (GuruFocus.com) -5.58%
11:41AM	Cars.com Inc. (NYSE:CARS) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 09:30AM	Cars.com (CARS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +9.20%
07:35AM	Cars.com (NYSE:CARS) Reports Q1 In Line With Expectations (StockStory)
07:35AM	Cars.com: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Cars.com Reports First Quarter 2024 Results (PR Newswire)
May-08-24 03:05AM	Cars.com (CARS) Q1 Earnings: What To Expect (StockStory)
Apr-28-24 09:04AM	5 Best Used Car Websites in USA (Insider Monkey)
Apr-25-24 07:30AM	Cars.com to Announce First Quarter 2024 Financial Results (PR Newswire)
07:30AM	Loading…
Apr-16-24 07:30AM	Market Prices, Consumer Budgets Inch Closer Together, According to Cars.com's 2024 Affordability Report (PR Newswire)
Apr-11-24 07:30AM	Tax Season Turbocharges Car Market: Dealers and Buyers Gear Up for a Surge in Shopping Activity, According to Cars Commerce March Industry Insights Report (PR Newswire)
Apr-03-24 05:48AM	Q4 Rundown: Cars.com (NYSE:CARS) Vs Other Online Marketplace Stocks (StockStory)
Apr-02-24 07:30AM	Cars.com's Your Garage Gives Car Owners Market Power for Trade-Ins and New Purchases, Showcased in Latest 'Possibilities' Ad (PR Newswire)
Mar-12-24 12:12AM	Insider Sell: Cars.com Inc (CARS) Pres. and Chief Comm. Officer Douglas Miller Sells 16,167 Shares (GuruFocus.com)
Mar-06-24 07:30AM	The Reviews Are In: Cars.com 2024 Dealer of the Year Awards Recognize the Best Local Car-Shopping Experiences Across America (PR Newswire)
Feb-28-24 11:27PM	Insider Sell: Cars.com Inc (CARS) President and Chief Communications Officer Douglas Miller ... (GuruFocus.com)
Feb-26-24 08:43AM	New Cars Are Finally Becoming More Affordable (Barrons.com)
08:43AM	Car Prices Are Finally Coming Down. It Looks Like a Buyers Market. (Barrons.com)
01:00AM	New Cars Are Becoming More Affordable. Thats Good for Buyers and Auto Stocks. (Barrons.com)
Feb-24-24 08:30AM	Top reasons why 2024 is the year to buy an EV or new car (Yahoo Finance Video)
Feb-23-24 12:07PM	Cars.com Inc. (NYSE:CARS) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:19AM	Q4 2023 Cars.com Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 09:30AM	Compared to Estimates, Cars.com (CARS) Q4 Earnings: A Look at Key Metrics (Zacks)
08:40AM	Cars.com (CARS) Lags Q4 Earnings Estimates (Zacks)
08:12AM	Loading…
08:12AM	Cars.com Inc (CARS) Reports Robust Revenue Growth and Record Traffic in 2023 (GuruFocus.com)
07:47AM	Cars.com: Q4 Earnings Snapshot (Associated Press Finance)
07:43AM	Cars.com (NYSE:CARS) Reports Q4 In Line With Expectations (StockStory)
07:30AM	Cars.com Reports Fourth Quarter and Full Year 2023 Results (PR Newswire)
Feb-21-24 02:01AM	Cars.com (CARS) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-19-24 09:15AM	Ahead of Cars.com (CARS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Feb-16-24 11:42PM	Cars.com Inc CEO Thomas Vetter Sells 17,666 Shares (GuruFocus.com)
Feb-12-24 04:30PM	Cars.com to Announce Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
02:06PM	Volkswagen's 'An American Love Story' Ad Zooms Ahead With 394% Surge in Traffic on Cars.com During the Big Game (PR Newswire)
Feb-07-24 07:30AM	Cars.com Reveals 2024 Best Of Awards: Budget-Friendly Chevrolet Trax Takes Top Spot as Best Car of the Year (PR Newswire)
Jan-30-24 07:30AM	Cars Commerce Addresses Automotive Retailers' Top Three Pain Points to Help Them Unleash Growth in 2024 (PR Newswire)
Jan-24-24 07:30AM	FordDirect Selects AccuTrade as its Preferred Vehicle Acquisition and Trade and Appraisal Solution For Its 3000+ U.S. Ford Dealers and Lincoln Retailers to Turn More Cars for More Profit (PR Newswire)
Jan-15-24 01:37AM	Q3 Earnings Highlights: Cars.com (NYSE:CARS) Vs The Rest Of The Online Marketplace Stocks (StockStory)
Jan-03-24 07:30AM	2024 Automotive Trends: Cars Commerce Explores Driving Forces Transforming Car Buying and Selling (PR Newswire)
Dec-02-23 01:04AM	Insider Sell Alert: CFO Sonia Jain Sells 22,328 Shares of Cars.com Inc (GuruFocus.com)
Nov-30-23 01:04PM	Insider Sell Alert: CFO Sonia Jain Sells 39,191 Shares of Cars.com Inc (GuruFocus.com)
07:30AM	13 Million Reviews Don't Lie: Cars.com Reveals Top Automakers With the Best Reputation (PR Newswire)
Nov-16-23 05:13PM	CarMax, Carvana Shares Tumble After Amazon Says It Will Sell Cars (Investopedia)
Nov-15-23 11:03PM	Insider Sell: CEO Thomas Vetter Sells 38,932 Shares of Cars.com Inc (GuruFocus.com)
Nov-09-23 07:00AM	Cars.com to Participate in Three Investor Conferences in November (PR Newswire)
Nov-04-23 12:48PM	Cars.com Inc. (NYSE:CARS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-03-23 02:03AM	Q3 2023 Cars.com Inc Earnings Call (Thomson Reuters StreetEvents) +7.79%
Nov-02-23 10:30AM	Compared to Estimates, Cars.com (CARS) Q3 Earnings: A Look at Key Metrics (Zacks) +11.69%
09:15AM	Cars.com Inc (CARS) Reports 6% Revenue Growth and $4.5 Million Net Income in Q3 2023 (GuruFocus.com)
08:10AM	Cars.com: Q3 Earnings Snapshot (Associated Press Finance)
07:33AM	Cars.com's (NYSE:CARS) Q3 Earnings Results: Revenue In Line With Expectations But Usage Drops (StockStory)
07:30AM	Cars.com Inc. Reports Third Quarter 2023 Results (PR Newswire)
07:15AM	Cars.com Inc. Acquires D2C Media Inc., Expanding Cars Commerce Platform into Canada in Accretive Transaction (PR Newswire)
Nov-01-23 03:07AM	Cars.com (CARS) Q3 Earnings: What To Expect (StockStory)
Oct-25-23 07:30AM	Cars.com to Announce Third Quarter 2023 Financial Results (PR Newswire)
Oct-17-23 07:30AM	CARS Rebrands Commercial Enterprise as Cars Commerce, the First Connected Platform for Automotive That Spans Pretail, Retail and Post-Sale (PR Newswire)
Sep-28-23 07:00AM	Car Sales Are Slowing. Car-Listing Websites Are Just Getting Started. (The Wall Street Journal)
Sep-27-23 07:30AM	CARS.COM FINDS AMERICANS PAY A PREMIUM FOR PICKUP TRUCK 'COOL FACTOR' (PR Newswire)
Sep-19-23 07:34PM	Unveiling Cars.com (CARS)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-15-23 12:35PM	Cars.com (CARS): A Thorough Examination of Its Modest Overvaluation (GuruFocus.com) -6.84%
12:06PM	Unraveling the Future of Cars.com Inc (CARS): A Deep Dive into Key Metrics (GuruFocus.com)
Aug-03-23 07:53AM	Does Cars.com (NYSE:CARS) Deserve A Spot On Your Watchlist? (Simply Wall St.) -5.39%
07:42AM	Cars.com: Q2 Earnings Snapshot (AP Finance)
07:30AM	CARS Reports Second Quarter 2023 Results (PR Newswire)
Aug-02-23 05:25PM	Revolve Group (RVLV) Tops Q2 Earnings Estimates (Zacks)
Aug-01-23 07:30AM	A Third Child Means a New Ride for 40% of Parents; Cars.com's Car Seat Fit Report Card Shares the Best Family-Friendly Vehicles for Growing Families (PR Newswire)
Jul-20-23 07:30AM	CARS to Announce Second Quarter 2023 Financial Results (PR Newswire)
Jul-02-23 07:45PM	Safe Place in Uneven Macro: J.P. Morgan Sees Multi-Year Revenue Growth for Auto Marketplace Platforms Here Are 2 Stocks to Take Advantage (TipRanks)
Jun-21-23 08:00PM	CARS: Raising target price to $20.00 (Argus Research)
03:52PM	Tesla Sweeps Top Spots in Cars.com American Made Index. Ford, GM Fall Off. (Barrons.com)
07:30AM	CARS.COM AMERICAN-MADE INDEX SEES 260% JUMP IN ELECTRIFIED VEHICLES SINCE 2020, TESLA LANDS TOP SPOTS (PR Newswire)
Jun-20-23 09:05AM	Tesla May Have a Demand Problem With One of Its Models (Barrons.com)
Jun-01-23 07:30AM	CARS.COM'S NEWEST MODEL: A MODERN BRAND, FRESH AD CAMPAIGN AND ENDLESS 'POSSIBILITIES' (PR Newswire)
May-12-23 06:20AM	Is Cars.com Inc. (NYSE:CARS) Trading At A 32% Discount? (Simply Wall St.)
May-11-23 07:30AM	CARS to Participate in Two Investor Conferences in May (PR Newswire)
May-04-23 02:38PM	Why Cars.com Stock Dropped on Thursday (Motley Fool) -11.71%
07:38AM	Cars.com: Q1 Earnings Snapshot (AP Finance)
07:30AM	CARS Reports First Quarter 2023 Results (PR Newswire)
Apr-26-23 08:00PM	CARS: Lowering target price to $15.00 (Argus Research)
Apr-20-23 07:30AM	CARS to Announce First Quarter 2023 Financial Results (PR Newswire)
Apr-15-23 08:33AM	Based On Its ROE, Is Cars.com Inc. (NYSE:CARS) A High Quality Stock? (Simply Wall St.)
Mar-29-23 12:58PM	Cars.com's (NYSE:CARS) investors will be pleased with their incredible 367% return over the last three years (Simply Wall St.)
07:50AM	CARS.COM RELEASES ITS 2023 TOP PICKS FOR ELECTRIC VEHICLES (PR Newswire)
07:30AM	FROM AFFORDABILITY TO CAPABILITY, CARS.COM'S 2023 EV BUYING GUIDE NAVIGATES SHOPPERS THROUGH THE EVER EV-OLVING ELECTRIC VEHICLE FRONTIER (PR Newswire)
Mar-13-23 06:56AM	Why Cars.com Inc. (NYSE:CARS) Could Be Worth Watching (Simply Wall St.)
Mar-09-23 07:30AM	DealerRater Celebrates 2023 Dealer of the Year Award Winners: More Than 1 Million Car Buyers Last Year Rated Dealerships on the Best Customer Experience (PR Newswire)
Feb-27-23 03:47PM	Cars.com Is Firing On All Cylinders, Says This Analyst (Benzinga)
Feb-24-23 11:03AM	Why Cars.com Stock Is Rising 11% This Week (Motley Fool)
05:38AM	Here's Why We Think Cars.com (NYSE:CARS) Is Well Worth Watching (Simply Wall St.)
Feb-23-23 01:17PM	Why Cars.com Stock Popped Today (Motley Fool) +12.54%
10:15AM	Cars.com (CARS) Q4 Earnings Miss Estimates (Zacks)
07:30AM	CARS Reports Fourth Quarter and Full Year 2022 Results (PR Newswire)
Feb-13-23 11:56AM	AUTOMAKERS GET A 'BIG GAME BOOST' ON CARS.COM FOLLOWING PRIMETIME ADS, GAINING A COLLECTIVE 81% SPIKE IN TRAFFIC TO THEIR INVENTORY (PR Newswire)
Feb-09-23 08:00AM	CARS to Announce Fourth Quarter and Full Year 2022 Financial Results (PR Newswire)
Feb-07-23 12:55PM	KIA CLINCHES TOP SPOT IN CARS.COM'S 2023 'BEST OF' AWARDS (PR Newswire)

Cars.com, Inc. engages in the provision of an automotive marketplace platform and digital solutions that connect car shoppers with sellers. Its portfolio of brands includes Dealer Inspire, FUEL, DealerRater, CreditIQ, and NewCars.com. The company was founded by Mitch Golub, William Swislow, and T. Alex Vetter in 1998 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Vetter Thomas Alex	CEO	May 28 '24	Sale	19.00	25,373	482,087	634,274	May 30 05:51 PM
Marks Angelique Strong	Chief Legal Officer	May 24 '24	Sale	18.57	16,989	315,486	101,928	May 28 05:57 PM
Marks Angelique Strong	Chief Legal Officer	May 23 '24	Sale	18.50	2,846	52,651	118,917	May 28 05:57 PM
Vetter Thomas Alex	CEO	May 09 '24	Sale	19.00	27,625	524,875	659,647	May 13 04:55 PM
Miller Douglas Neal	Pres. and Chief Comm. Officer	Mar 08 '24	Sale	18.54	14,344	265,938	167,252	Mar 11 05:16 PM
Miller Douglas Neal	Pres. and Chief Comm. Officer	Mar 07 '24	Sale	18.50	1,823	33,726	181,596	Mar 11 05:16 PM
Miller Douglas Neal	Pres. and Chief Comm. Officer	Mar 06 '24	Sale	18.15	16,167	293,431	183,419	Mar 07 04:20 PM
Vetter Thomas Alex	CEO	Feb 15 '24	Sale	19.00	2,667	50,673	551,219	Feb 16 05:02 PM
Vetter Thomas Alex	CEO	Feb 14 '24	Sale	19.00	14,999	284,981	553,886	Feb 16 05:02 PM
Vetter Thomas Alex	CEO	Feb 12 '24	Sale	19.00	17,666	335,654	568,885	Feb 14 04:31 PM
Vetter Thomas Alex	CEO	Dec 14 '23	Sale	19.00	17,666	335,654	586,551	Dec 18 05:40 PM
Jain Sonia	Chief Financial Officer	Nov 30 '23	Sale	18.64	13,889	258,891	233,470	Dec 01 04:19 PM
Jain Sonia	Chief Financial Officer	Nov 29 '23	Sale	18.90	8,439	159,497	247,359	Dec 01 04:19 PM
Jain Sonia	Chief Financial Officer	Nov 28 '23	Sale	18.92	17,235	326,086	255,798	Nov 29 04:44 PM
Jain Sonia	Chief Financial Officer	Nov 27 '23	Sale	19.02	21,956	417,603	273,033	Nov 29 04:44 PM
Vetter Thomas Alex	CEO	Nov 14 '23	Sale	19.33	17,666	341,484	604,217	Nov 15 04:43 PM
Vetter Thomas Alex	CEO	Nov 13 '23	Sale	19.00	21,266	404,054	621,883	Nov 15 04:43 PM
Marks Angelique Strong	Chief Legal Officer	Nov 09 '23	Sale	18.52	5,594	103,601	87,105	Nov 13 04:52 PM
Vetter Thomas Alex	CEO	Nov 08 '23	Sale	19.00	14,066	267,254	643,149	Nov 13 05:01 PM
Marks Angelique Strong	Chief Legal Officer	Nov 08 '23	Sale	18.79	4,263	80,102	92,699	Nov 13 04:52 PM
Vetter Thomas Alex	CEO	Aug 24 '23	Sale	19.00	17,666	335,654	657,215	Aug 28 04:34 PM
WIENER BRYAN	Director	Jun 14 '23	Sale	18.29	15,000	274,350	72,913	Jun 16 04:31 PM
Miller Douglas Neal	Pres. and Chief Comm. Officer	Jun 07 '23	Sale	18.88	15,790	298,115	237,741	Jun 09 04:04 PM
Marks Angelique Strong	Chief Legal Officer	Jun 06 '23	Sale	18.50	6,000	111,000	96,962	Jun 08 05:02 PM
McGovern Jr. Donald A.	Director	Jun 05 '23	Sale	17.82	7,000	124,740	68,231	Jun 06 05:10 PM

Open in Screener

ATNF

180 Life Sciences Corp

May 31 • 04:00PM ET

1.62

Dollar change +0.01
Percentage change 0.62	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

ATNF 180 Life Sciences Corp daily Stock Chart

Held by: VXF

Index	-	P/E	-	EPS (ttm)	-29.20	Insider Own	3.35%	Shs Outstand	0.53M	Perf Week	-2.41%
Market Cap	0.86M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.52M	Perf Month	-18.59%
Income	-16.24M	PEG	-	EPS next Q	-	Inst Own	4.23%	Short Float	3.32%	Perf Quarter	-49.85%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	0.10	Perf Half Y	-69.66%
Book/sh	-1.12	P/B	-	EPS next Y	-	ROA	-176.90%	Short Interest	0.02M	Perf Year	-92.52%
Cash/sh	1.28	P/C	1.26	EPS next 5Y	-	ROE	-525.19%	52W Range	1.31 - 26.03	Perf YTD	-60.06%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-93.78%	Beta	-
Dividend TTM	-	Quick Ratio	0.45	Sales past 5Y	0.00%	Gross Margin	-	52W Low	23.66%	ATR (14)	0.29
Dividend Ex-Date	-	Current Ratio	0.45	EPS Y/Y TTM	89.71%	Oper. Margin	0.00%	RSI (14)	41.81	Volatility	11.64% 15.98%
Employees	4	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	1520.00
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-31.86%	Payout	-	Rel Volume	0.10	Prev Close	1.61
Sales Surprise	-	EPS Surprise	84.62%	Sales Q/Q	-	Earnings	-	Avg Volume	178.87K	Price	1.62
SMA20	-10.94%	SMA50	-19.86%	SMA200	-71.60%	Trades		Volume	18,694	Change	0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-15-21	Initiated	Maxim Group	Buy	$11

May-16-24 11:53AM	ATNF Stock Earnings: 180 Life Sciences Reported Results for Q1 2024 (InvestorPlace) -14.95%
Mar-14-24 08:30AM	180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Feb-26-24 07:00AM	180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan (GlobeNewswire) +5.49%
Dec-04-23 09:00AM	180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives (GlobeNewswire)
Nov-28-23 09:00AM	180 Life Sciences Announces Review of Strategic Alternatives (GlobeNewswire) +7.70%
04:29PM	Loading…
Aug-14-23 04:29PM	180 Life Sciences Corp. Announces Closing of $3 Million Public Offering (GlobeNewswire)
Aug-10-23 08:46AM	180 Life Sciences Corp. Announces Pricing of $3 Million Public Offering (GlobeNewswire) -16.73%
Aug-07-23 09:00AM	180 Life Sciences Announces an Agreement for a Clinical Pharmacology Study Testing a New Formulation of CBD for Enhanced Oral Uptake (GlobeNewswire)
Aug-03-23 08:00AM	180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytrens Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA (GlobeNewswire)
Jul-31-23 08:00AM	180 Life Sciences Corp. Announces the Filing of a Provisional Patent Describing the Combination of CBD With GLP-1 Agonists to Suppress Appetite (GlobeNewswire)
Apr-10-23 04:30PM	180 Life Sciences Corp. Announces Closing of $3 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
Apr-05-23 01:00PM	180 Life Sciences Corp. Announces $3 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -19.66%
Feb-27-23 08:30AM	180 Life Sciences Announces Presentation at the Gordon Conference (GlobeNewswire) +5.51%
Feb-23-23 07:30AM	180 Life Sciences Announces Allowance of Claims for a US Patent for Dupuytrens Disease Treatment and Application (GlobeNewswire) -10.82%
Feb-22-23 04:30PM	180 Life Sciences Provides Update Regarding Anti-TNF Frozen Shoulder Trial (GlobeNewswire)
08:45AM	Loading…
Jan-25-23 08:45AM	180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytrens Disease (GlobeNewswire) +33.75%
Jan-17-23 08:00AM	180 Life Sciences Engages Kinexum for Assistance in Applying for Marketing Authorisation in the United Kingdom (GlobeNewswire)
Jan-05-23 08:30AM	180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +12.33%
Jan-04-23 08:30AM	180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytrens Disease (GlobeNewswire) -17.36%
Dec-29-22 08:30AM	180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders (GlobeNewswire) +13.86%
Dec-23-22 08:00AM	180 Life Sciences Corp. Announces Closing of $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -21.52%
Dec-20-22 02:11PM	180 Life Sciences Corp. Announces $6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -15.85%
Dec-16-22 09:00AM	180 Life Sciences Corp. Announces 1-for 20 Reverse Stock Split as Part of Nasdaq Compliance Plan (GlobeNewswire) -11.67%
Nov-30-22 05:00PM	180 Life Sciences Provides Update on Progress To Seek Medicines and Healthcare Products Regulatory Agency Marketing Authorization for Anti-TNF Treatment of Early Stage Dupuytrens Contracture (GlobeNewswire)
Nov-21-22 08:30AM	180 Life Sciences to Participate in A.G.P.s Virtual Biotech Conference to be Held November 30 December 1, 2022 (GlobeNewswire) -12.87%
Nov-15-22 12:37PM	CORRECTION: Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytrens Disease (GlobeNewswire) +12.02%
08:00AM	Adalimumab Found To Be A Likely Cost-Effective Treatment for Early-Stage Dupuytrens Disease (GlobeNewswire)
Sep-26-22 08:30AM	180 Life Sciences Issues Letter to Stockholders (GlobeNewswire)
Aug-22-22 08:30AM	180 Life Sciences with the University of Oxford Announce the Enrollment of the First Patient in a Trial of Anti-TNF for People with Early-Stage Frozen Shoulder (GlobeNewswire) -10.53%
Jul-27-22 08:30AM	180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program With 180 Life Sciences Corp. (GlobeNewswire)
08:00AM	Loading…
Jul-21-22 08:00AM	180 Life Sciences Corp. Announces Closing of $6.5 Million Registered Direct Offering (GlobeNewswire) +5.65%
Jul-18-22 08:30AM	180 Life Sciences Corp. Announces $6.5 Million Registered Direct Offering (GlobeNewswire)
Jun-22-22 04:05PM	180 Life Sciences Corp. Issues Letter to Stockholders (GlobeNewswire)
Jun-14-22 04:15PM	180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytrens Disease (GlobeNewswire)
May-31-22 08:30AM	180 Life Sciences Begins Consultations with UK and US Regulatory Authorities on Pathway for a Therapy that Could Prevent Progression of Early-Stage Dupuytrens Disease (GlobeNewswire) +18.25%
May-02-22 08:00AM	REPEAT - 180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytrens Disease Study Results in The Lancet Rheumatology (GlobeNewswire) -20.75%
Apr-29-22 06:32PM	180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytrens Disease Study Results in The Lancet Rheumatology (GlobeNewswire) +22.54%
Feb-17-22 08:30AM	180 Life Sciences Corp. Forms Scientific Advisory Board (GlobeNewswire) -6.61%
Jan-31-22 08:00AM	180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders (GlobeNewswire) +7.12%
Dec-28-21 11:00AM	180 Life Sciences Corp. To Participate in the Biotech Showcase 2022 Virtual Conference To be Held January 10-12, 2022 (GlobeNewswire) -5.75%
Dec-15-21 08:15AM	180 Life Sciences Corp. Enters into a License Agreement with University of Oxford for Regenerative Molecule HMGB1 for Liver Diseases (GlobeNewswire)
Dec-12-21 06:06AM	Insider Buying: The 180 Life Sciences Corp. (NASDAQ:ATNF) Lead Independent Director Just Bought 328% More Shares (Simply Wall St.)
Dec-10-21 05:15PM	180 Life Sciences Corp (ATNF) CEO James N. Woody Bought $53,375 of Shares (GuruFocus.com)
Dec-06-21 08:15AM	180 Life Sciences Provides Follow-Up Information on Oxford University and the Companys Successful Dupuytrens Phase 2b Clinical Trial Results (GlobeNewswire) +7.95%
Dec-01-21 02:45PM	180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical Trial (GlobeNewswire) -20.85%
02:26PM	180 Life Sciences: Positive Data From Dupuytrens Disease Study Could Be a Big Catalyst, Says Analyst (TipRanks)
Nov-22-21 08:30AM	180 Life Sciences Corp. Expands Patent Portfolio (GlobeNewswire)
Nov-18-21 08:15AM	180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium (GlobeNewswire) +9.86%
Nov-03-21 12:06PM	180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer (GlobeNewswire)
Oct-26-21 08:30AM	180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal Molecules (GlobeNewswire)
Sep-30-21 08:30AM	180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio (GlobeNewswire) +5.66%
Sep-20-21 08:00AM	Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agreement for the Ongoing Supply of Drug for Anti-TNF Product Trials for Novel Indications (GlobeNewswire) -6.29%
Aug-30-21 08:30AM	180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders (GlobeNewswire)
Aug-24-21 08:30AM	180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement (GlobeNewswire)
Aug-19-21 09:00AM	180 Life Sciences Corp. Announces $15.0 Million Private Placement (GlobeNewswire) -25.73%
08:10AM	Is 180 Life Sciences Corp.'s (NASDAQ:ATNF) Shareholder Ownership Skewed Towards Insiders? (Simply Wall St.)
Aug-02-21 08:00AM	Chairman of the 180 Life Sciences Clinical Advisory Board, Professor Jagdeep Nanchahal, has Been Invited To Present a Keynote Talk at the British Society for Surgery of the Hand (BSSH) at the Autumn Scientific Meeting in Oxford UK on September 9, 2021 (GlobeNewswire)
Jul-29-21 08:00AM	180 Life Sciences to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference (GlobeNewswire)
Jul-28-21 08:15AM	180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue (GlobeNewswire)
Jul-20-21 08:00AM	180 Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1) (GlobeNewswire)
Jul-12-21 09:51AM	180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2) (GlobeNewswire) +9.75%
Jul-07-21 08:00AM	180 Life Sciences Expands Scientific Fibrosis Platform with Collagen VI as a Driver and Disease Biomarker in Human Fibrosis Published in the FEBS Journal (GlobeNewswire)
Jun-28-21 08:15AM	180 Life Sciences Joins Russell Microcap® Index (GlobeNewswire)
08:00AM	180 Life Sciences Files Plan with Nasdaq Related to Delayed Quarterly Report on Form 10-Q and Form 10-K (GlobeNewswire)
Jun-10-21 09:12AM	180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors (GlobeNewswire)
Jun-01-21 08:00AM	180 Life Sciences Corp. to Present at LD Micro Invitational XI (GlobeNewswire) +8.90%
May-28-21 08:00AM	180 Life Sciences Corp. Announces the Appointment of Russell T. Ray, MBA and Teresa DeLuca MD, MBA to Board of Directors (GlobeNewswire) +7.96%
May-21-21 04:45PM	180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q (GlobeNewswire) +10.61%
Apr-20-21 08:00AM	180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytrens Disease Trial (GlobeNewswire)
Apr-19-21 05:00PM	180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K (GlobeNewswire) -16.53%
Apr-14-21 08:15AM	180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021 (GlobeNewswire)
Mar-26-21 08:30AM	180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics (GlobeNewswire) +18.57%
Mar-25-21 08:30AM	180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters (GlobeNewswire) +13.65%
Mar-24-21 08:30AM	180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders (GlobeNewswire)
Mar-08-21 01:30PM	180 Life Sciences Corp. to Present at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC (GlobeNewswire) +5.46%
Feb-24-21 04:00PM	180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement (GlobeNewswire) +11.06%
Feb-19-21 09:00AM	180 Life Sciences Corp. Announces $11.7 Million Private Placement (GlobeNewswire) -13.46%
Feb-17-21 12:00AM	Do Insiders Own Lots Of Shares In 180 Life Sciences Corp. (NASDAQ:ATNF)? (Simply Wall St.) -5.45%
Jan-11-21 08:00AM	180 Life Sciences Corp. to Present at the Biotech Showcase(TM) Digital 2021 Conference (Newsfile) +5.06%
Jan-05-21 02:50PM	180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference (GlobeNewswire) +7.17%
Dec-03-20 11:08AM	180 Life Sciences Corp. to Present at the 13th Annual LD Micro Main Event Conference on Tuesday, December 15th at 1:40 PM EST (GlobeNewswire)
Nov-24-20 10:00AM	180 Life Sciences Corp. to Ring Nasdaq Opening Bell on November 27, 2020 (GlobeNewswire) -6.93%
Nov-23-20 08:30AM	180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants (GlobeNewswire) +17.44%
Nov-17-20 08:00AM	180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders (GlobeNewswire)
Nov-10-20 11:46AM	180 Life Sciences Announces Completion of Transaction with KBLM Merger Corp IV (GlobeNewswire) -6.47%

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Woody James N.	Chief Executive Officer	Dec 15 '23	Buy	0.19	25,000	4,700	66,888	Dec 18 04:15 PM
Feldmann Marc	Director	Dec 15 '23	Sale	0.19	25,000	4,700	115,497	Dec 18 04:15 PM
STEINMAN LAWRENCE	Director	Jun 01 '23	Buy	1.23	18,000	22,068	48,129	Jun 02 08:00 AM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

CARS

Cars.com

ATNF

180 Life Sciences Corp

Upgrade your FINVIZ experience